Logo image of ORGN

ORIGIN MATERIALS INC (ORGN) Stock Fundamental Analysis

NASDAQ:ORGN - Nasdaq - US68622D1063 - Common Stock - Currency: USD

0.9669  -0.07 (-7.03%)

After market: 0.9597 -0.01 (-0.74%)

Fundamental Rating

2

Taking everything into account, ORGN scores 2 out of 10 in our fundamental rating. ORGN was compared to 85 industry peers in the Chemicals industry. While ORGN seems to be doing ok healthwise, there are quite some concerns on its profitability. ORGN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ORGN had negative earnings in the past year.
In the past year ORGN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ORGN reported negative net income in multiple years.
In the past 5 years ORGN always reported negative operating cash flow.
ORGN Yearly Net Income VS EBIT VS OCF VS FCFORGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M -100M -150M

1.2 Ratios

ORGN has a worse Return On Assets (-20.18%) than 89.16% of its industry peers.
The Return On Equity of ORGN (-22.46%) is worse than 81.93% of its industry peers.
Industry RankSector Rank
ROA -20.18%
ROE -22.46%
ROIC N/A
ROA(3y)9.77%
ROA(5y)N/A
ROE(3y)13.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ORGN Yearly ROA, ROE, ROICORGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10K -20K -30K

1.3 Margins

ORGN has a Gross Margin of 11.37%. This is amonst the worse of the industry: ORGN underperforms 80.72% of its industry peers.
ORGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ORGN Yearly Profit, Operating, Gross MarginsORGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

ORGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ORGN has more shares outstanding
ORGN has a better debt/assets ratio than last year.
ORGN Yearly Shares OutstandingORGN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M
ORGN Yearly Total Debt VS Total AssetsORGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.07 indicates that ORGN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ORGN has a Altman-Z score (2.07) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.02 indicates that ORGN is not too dependend on debt financing.
The Debt to Equity ratio of ORGN (0.02) is better than 92.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 2.07
ROIC/WACCN/A
WACC9.01%
ORGN Yearly LT Debt VS Equity VS FCFORGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

ORGN has a Current Ratio of 16.27. This indicates that ORGN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 16.27, ORGN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ORGN has a Quick Ratio of 16.16. This indicates that ORGN is financially healthy and has no problem in meeting its short term obligations.
ORGN's Quick ratio of 16.16 is amongst the best of the industry. ORGN outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.27
Quick Ratio 16.16
ORGN Yearly Current Assets VS Current LiabilitesORGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

ORGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -231.43%.
ORGN shows a strong growth in Revenue. In the last year, the Revenue has grown by 123.14%.
EPS 1Y (TTM)-231.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
Revenue 1Y (TTM)123.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.87%

3.2 Future

Based on estimates for the next years, ORGN will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.21% on average per year.
Based on estimates for the next years, ORGN will show a very strong growth in Revenue. The Revenue will grow by 67.78% on average per year.
EPS Next Y-460%
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%
EPS Next 5Y-20.21%
Revenue Next Year11.22%
Revenue Next 2Y41.59%
Revenue Next 3Y35.53%
Revenue Next 5Y67.78%

3.3 Evolution

ORGN Yearly Revenue VS EstimatesORGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
ORGN Yearly EPS VS EstimatesORGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ORGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORGN Price Earnings VS Forward Price EarningsORGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORGN Per share dataORGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

A cheap valuation may be justified as ORGN's earnings are expected to decrease with -38.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%

More info and screens

0

5. Dividend

5.1 Amount

ORGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORIGIN MATERIALS INC

NASDAQ:ORGN (2/21/2025, 8:00:02 PM)

After market: 0.9597 -0.01 (-0.74%)

0.9669

-0.07 (-7.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-13 2025-03-13/amc
Inst Owners18.2%
Inst Owner Change2.04%
Ins Owners14.74%
Ins Owner Change-0.93%
Market Cap141.41M
Analysts45.71
Price Target3.32 (243.37%)
Short Float %5.37%
Short Ratio5.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.03%
Min EPS beat(2)-33.69%
Max EPS beat(2)-14.38%
EPS beat(4)2
Avg EPS beat(4)1.22%
Min EPS beat(4)-33.69%
Max EPS beat(4)50.98%
EPS beat(8)6
Avg EPS beat(8)89.63%
EPS beat(12)10
Avg EPS beat(12)150.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)37.06%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)77.24%
Revenue beat(4)3
Avg Revenue beat(4)21.03%
Min Revenue beat(4)-3.12%
Max Revenue beat(4)77.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.33%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.03
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.24
BVpS2.45
TBVpS2.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.18%
ROE -22.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.37%
FCFM N/A
ROA(3y)9.77%
ROA(5y)N/A
ROE(3y)13.45%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 167.77%
Cap/Sales 48.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.27
Quick Ratio 16.16
Altman-Z 2.07
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)5723.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-231.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.18%
EPS Next Y-460%
EPS Next 2Y-111.19%
EPS Next 3Y-38.56%
EPS Next 5Y-20.21%
Revenue 1Y (TTM)123.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%14.87%
Revenue Next Year11.22%
Revenue Next 2Y41.59%
Revenue Next 3Y35.53%
Revenue Next 5Y67.78%
EBIT growth 1Y-34.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.51%
EBIT Next 3Y9.01%
EBIT Next 5Y22.39%
FCF growth 1Y6.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-271.71%
OCF growth 3YN/A
OCF growth 5YN/A